JVM Co

JVM Co Operating Expenses

The Total Operating Expenses of JVM Co (054950.KQ) as of Nov 3, 2026 is 21.36 B KRW. In the previous year, Total Operating Expenses was 31.05 B KRW — a change of -31.21% (lower).

Operating Expenses

21.36 BKRW

YoY

-31.21%

Last updated:

Total Operating Expenses of JVM Co is 2025 21.36 B KRW. Total Operating Expenses of JVM Co was 2024 31.05 B KRW. It decreases by -31.21% lower compared to the previous year.

The JVM Co Operating Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Expenses
Date
Operating Expenses
Jan 1, 2018
25.25 B KRW
Jan 1, 2019
26.44 B KRW
Jan 1, 2020
24.66 B KRW
Jan 1, 2021
24.89 B KRW
Jan 1, 2022
27.17 B KRW
Jan 1, 2023
30.87 B KRW
Jan 1, 2024
31.05 B KRW
Jan 1, 2025
21.36 B KRW
The JVM Co Operating Expenses history
YEAROperating ExpensesYoY
21.36 BKRW-31.21%
31.05 BKRW+0.58%
30.87 BKRW+13.64%
27.17 BKRW+9.15%
24.89 BKRW+0.95%
24.66 BKRW-6.75%
26.44 BKRW+4.73%
25.25 BKRW+3.39%
24.42 BKRW-4.03%
25.45 BKRW-14.44%
29.74 BKRW-1.57%
30.21 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

JVM Co Stock analysis

What does JVM Co do? JVM Co., Ltd. manufactures pharmacy automation systems under the brand JVM, targeting domestic and overseas markets. The company's primary products include automatic tablet dispensing and packaging systems (ATDPSs), automatic tablet classification and packing machines available in slide, box, and drum types, total safety solutions, automatic medication vision inspection systems (VIZENs), automatic package cutting and winding systems (WIZERs), and automatic medication sorting and control systems (AccuPharm). These products are sold to customers in the pharmaceutical and healthcare sectors seeking efficient automation solutions for medication handling and safety. The firm generates revenue through the sale of its branded automation systems, with a focus on domestic distribution and international markets. JVM's product portfolio addresses key operational needs in pharmacy settings, including dispensing, classification, inspection, and sorting of medications, ensuring compliance with safety standards while improving workflow efficiency. The company's offerings are designed to meet the demands of healthcare providers and pharmaceutical manufacturers requiring advanced automation technologies. JVM's business model centers on providing comprehensive automation solutions for pharmacy operations, leveraging its established brand JVM to differentiate its products in the market. By offering a wide range of specialized systems, the company caters to both domestic and international clients seeking reliable, high-quality automation equipment for medication management and safety protocols. JVM Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JVM Co stock

Total Operating Expenses of JVM Co is 21.36 B KRW in 2025.

Total Operating Expenses of JVM Co changed from 31.05 B KRW to 21.36 B KRW, representing a -31.21% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Operating Expenses JVM Co since 2006 – with annual values, charts, and detailed analysis.

Operating expenses are the costs incurred in the normal course of business operations, including COGS, SG&A, R&D, and depreciation.

Total Operating Expenses's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Operating Expenses's JVM Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — JVM Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — JVM Co